New hope for CIDP patients: Long-Term batoclimab safety trial underway
NCT ID NCT07188844
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This study looks at the long-term safety of a drug called batoclimab for adults with CIDP, a nerve disorder that causes weakness and numbness. About 108 people who completed a previous study will get weekly injections for up to a year. The goal is to see if the drug is safe and tolerable over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site Number - 1601
Austin, Texas, 78759, United States
-
Site Number - 1610
Charlotte, North Carolina, 28207, United States
-
Site Number - 1611
Nicholasville, Kentucky, 40356, United States
-
Site Number - 1617
Ormond Beach, Florida, 32174, United States
-
Site Number - 1621
New Haven, Connecticut, 06519, United States
-
Site Number - 3201
Katowice, Silesian Voivodeship, 40-123, Poland
-
Site Number - 3206
Lublin, Lublin Voivodeship, 20-701, Poland
-
Site Number - 3207
Poznan, Greater Poland Voivodeship, 61-731, Poland
-
Site Number - 3208
Krakow, Lesser Poland Voivodeship, 30-688, Poland
-
Site Number - 3209
Krakow, Lesser Poland Voivodeship, 31-202, Poland
-
Site Number - 3210
Lublin, Lublin Voivodeship, 20-064, Poland
-
Site Number - 4680
Leuven, Vlaams Brabant, 3000, Belgium
-
Site Number - 6305
Bologna, Emilia-Romagna, 40139, Italy
-
Site Number - 6307
Milan, Lombardy, 20132, Italy
-
Site Number - 6309
Rome, Lazio, 00133, Italy
-
Site Number - 6341
Pátrai, Achaïa, 265 04, Greece
-
Site Number - 6344
Athens, Attica, 115 25, Greece
-
Site Number - 6347
Larissa, 41110, Greece
-
Site Number - 6702
Leipzig, Saxony, 04103, Germany
-
Site Number - 7750
Buenos Aires, C1199ABB, Argentina
-
Site Number - 7751
Rosario, Santa Fe Province, S2000DTP, Argentina
-
Site Number - 7752
San Miguel de Tucumán, T4000AXL, Argentina
-
Site Number - 7753
Rosario, Santa Fe Province, S2000BZL, Argentina
-
Site Number - 8400
Constanța, 900591, Romania
-
Site Number - 8403
Timișoara, Timiș County, 300736, Romania
-
Site Number - 8501
Belgrade, 11000, Serbia
-
Site Number - 8603
Prešov, 081 81, Slovakia
-
Site Number - 9100
Ribeirão Preto, São Paulo, 14048-900, Brazil
-
Site Number - 9101
Curitiba, Paraná, 81210-310, Brazil
-
Site Number - 9103
Brasília, Federal District, 70200-730, Brazil
Conditions
Explore the condition pages connected to this study.